Pharmacodynamic and safety study of reolysin in patients with advanced solid tumors

被引：0
|
作者：
Gollamudi, R.
Desai, K.
Chaudhary, I.
Ghalib, M. H.
Wong, B.
Einstein, M.
Coffey, M.
Gill, G.
Mani, S.
Goel, S.
机构：
[1] Montefiore Albert Einstein Canc Ctr, Bronx, NY USA
[2] Oncolyt Biotech Inc, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14004
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors
    Anne M. Traynor
    Michael S. Gordon
    Dona Alberti
    David S. Mendelson
    Mark S. Munsey
    George Wilding
    Richard E. Gammans
    William L. Read
    Investigational New Drugs, 2010, 28 : 509 - 515
  • [42] A Phase I Cardiac Safety and Pharmacokinetic Study of Tivozanib Hydrochloride in Patients With Advanced Solid Tumors
    Moore, Kathleen
    Infante, Jeffrey R.
    Cotreaua, Monette M.
    Wilson, Lindsey
    Strahs, Andrew L.
    Vargo, Dennis L.
    Chadha, Manpreet
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (04): : 284 - 289
  • [43] Safety and efficacy of copanlisib in combination with nivolumab: A phase Ib study in patients with advanced solid tumors
    Carneiro, Benedito A.
    Jotte, Robert
    Gabrail, Nashat
    Hamid, Omid
    Huang, Funan
    Chaturvedi, Shalini
    Herpers, Matthias
    Soler, Lidia Mongay
    Childs, Barrett H.
    Hansen, Aaron
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [44] Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors
    Carneiro, Benedito A.
    Jotte, Robert M.
    Gabrail, Nashat Y.
    Wentzel, Kristopher
    Huang, Funan
    Chaturvedi, Shalini
    Weispfenning, Anke
    Hiemeyer, Florian
    Morcos, Peter N.
    Soler, Lidia Mongay
    Childs, Barrett H.
    Hansen, Aaron R.
    CANCER RESEARCH COMMUNICATIONS, 2025, 5 (03): : 444 - 457
  • [45] Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
    Cascone, T.
    Sacks, R. L.
    Subbiah, I. M.
    Drobnitzky, N.
    Piha-Paul, S. A.
    Hong, D. S.
    Hess, K. R.
    Amini, B.
    Bhatt, T.
    Fu, S.
    Naing, A.
    Janku, F.
    Karp, D.
    Falchook, G. S.
    Conley, A. P.
    Sherman, S., I
    Meric-Bernstam, F.
    Ryan, A. J.
    Heymach, J., V
    Subbiah, V
    ESMO OPEN, 2021, 6 (02)
  • [46] Safety and pharmacokinetics of AMG 706 in patients with advanced solid tumors.
    Rosen, L
    Kurzrock, R
    Jackson, E
    Wathen, L
    Parson, M
    Eschenberg, M
    Mulay, M
    Purdom, M
    Yan, L
    Herbst, RS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 195S - 195S
  • [47] Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
    Nikolay Grechko
    Viera Skarbova
    Monika Tomaszewska-Kiecana
    Rodryg Ramlau
    Piotr Centkowski
    Yvette Drew
    Rafal Dziadziuszko
    Milada Zemanova
    Jeri Beltman
    Eileen Nash
    Jenn Habeck
    Mingxiang Liao
    Jim Xiao
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 259 - 270
  • [48] Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
    Grechko, Nikolay
    Skarbova, Viera
    Tomaszewska-Kiecana, Monika
    Ramlau, Rodryg
    Centkowski, Piotr
    Drew, Yvette
    Dziadziuszko, Rafal
    Zemanova, Milada
    Beltman, Jeri
    Nash, Eileen
    Habeck, Jenn
    Liao, Mingxiang
    Xiao, Jim
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (02) : 259 - 270
  • [49] Safety, pharmacokinetic (PK), and pharmacodynamic profiles of the WEE1 inhibitor IMP7068 in patients (pts) with advanced solid tumors
    Lin, C-C.
    Grewal, J.
    Sommerhalder, D.
    Bai, L-Y.
    Li, G.
    Schneider, R.
    Shen, L.
    Yeh, Y-M.
    Yin, R.
    Hsu, H-C.
    Baranda, J. C.
    Hsieh, C-Y.
    Cai, S. X.
    Tian, Y. E.
    Ma, N.
    Xia, H.
    Zhang, C.
    Li, B.
    Zhang, M.
    Yu, Z.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S760 - S761
  • [50] Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid Tumors
    Sessa, Cristiana
    Lorusso, Patricia
    Tolcher, Anthony
    Farace, Francoise
    Lassau, Nathalie
    Delmonte, Angelo
    Braghetti, Antonio
    Bahleda, Rastislav
    Cohen, Patrick
    Hospitel, Marie
    Veyrat-Follet, Christine
    Soria, Jean-Charles
    CLINICAL CANCER RESEARCH, 2013, 19 (17) : 4832 - 4842
12345